Signaling Pathways
- A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
- A2213 17-DMAG (Alvespimycin) HCl1 CitationTarget: HSP90Summary: Hsp90 inhibitor
- A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent
- A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: HER2 inhibitor,potent and selective
- A2251 Tivozanib (AV-951)Target: VEGFRSummary: VEGFR inhibitor,potent and selective
- A1630 Epothilone B (EPO906, Patupilone)Target: Microtubules/TubulinsSummary: Microtubule stabilizing macrolide
- A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
- A1404 Rigosertib sodium salt1 CitationTarget: PLKSummary: Plk1 inhibitor
- A1393 WZ8040Target: EGFRSummary: EGFR T790M inhibitor,irreversible amd potent
- A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor